An interventional study of RESTEPS in Suicide and Mental Health Stigma, sponsored by Butler Hospital. Not yet recruiting at 1 site in United States. Open to participants aged 15 Years to 25 Years. Per ClinicalTrials.gov, last updated 2026-10-29.
Sponsored by Butler Hospital · Not applicable, Interventional, and Treatment
A mental health program, called RESTEPS, will be developed for patients with early psychosis being treated in outpatient mental health centers, focusing on reducing suicide risk by targeting mental health stigma and social support. Youth (n = 35) with psychosis and current/past suicidal thoughts or behaviors will be recruited from community mental health centers to complete an initial open trial examining the feasibility and acceptability of RESTEPS, an 8-session intervention. Participants will be assessed at baseline, mid-intervention, post-intervention, and at a 6-month follow-up.
1,587 studies on the registry are indexed under Psychotic Disorders; 281 are open to participants now.
This study's planned enrollment of 35 is below the median of 65 across 1,320 interventional studies indexed under Psychotic Disorders.
Browse Psychotic Disorders studies →Butler Hospital is the lead sponsor of 119 studies on the registry; 14 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 4 (80%) have results posted.
Compared within Psychotic Disorders, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Suicide. The counts are of registry records indexed under each term, refreshed daily. How we classify →
The criteria were revised on the registry on Oct 29, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
RESTEPS is an 8-session intervention for youth with early psychosis in community treatment. It addresses social support and mental health stigma. A family member/friend of the participant is invited to participate in half of the treatment sessions.
Behavioral: RESTEPS
RESTEPS is an 8-session intervention for youth with early psychosis in community treatment. It addresses social support and mental health stigma. A family member/friend of the participant is invited to participate in half of the treatment sessions.
Acceptability
The CSQ-8 is a brief, 8-item self-report measure global client satisfaction. Items are measured on a 4-point Likert scale, with higher scores indicating higher levels of satisfaction. The CSQ-8 demonstrates internal consistency, in addition to predictive and convergent validity. A mean CSQ-8 score of ≥ 3 will be used as the satisfaction threshold in the current project.
Time frame: At post-intervention (8 weeks post-enrollment) and study follow-up (24 weeks post-enrollment)
Suicidal Ideation Questionnaire (SIQ)
The SIQ is a 15-item self-report measure of suicidal ideation over the past month. Items are rated on a 7- point scale assessing for frequency of thoughts ("almost every day" to "I never had this thought"). Scores range from 0 to 90, with a published clinical cut-off score of 31. It was developed for youth and has established convergent and predictive validity.
Time frame: At baseline, mid-intervention (4 weeks post enrollment), post-intervention (8 weeks post-enrollment), and study follow-up (24 weeks post-enrollment)
Brief Psychiatric Rating Scale (BPRS)
The BPRS is an 18-item clinical interview measure of psychopathology, including symptoms of psychosis (e.g., paranoia, hallucinations, delusions), over the past week. Each item is rated on a scale from 1 (not present) to 7 (extremely severe). A higher score on the BPRS suggests higher severity of psychopathology. The BPRS is commonly used in first-episode psychosis intervention studies and has established validity and reliability. The BPRS was designed for adults and the BPRS-C was designed for children/adolescents.
Time frame: At baseline, mid-intervention (4 weeks post enrollment), post-intervention (8 weeks post-enrollment), and study follow-up (24 weeks post-enrollment)
Plan to share: Yes — Inter-university Consortium for Political and Social Research (ICPSR)
No publications or documents are linked to this record.
Start is estimated for Dec 2026; primary completion for Jun 2028, 18 months later.
Of 455 non-industry interventional studies with no phase under Psychotic Disorders, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 52. This study's planned 18 months is below that.
Counting every sponsor, half of 457 studies reached it within 34 months; a quarter within 19 and three quarters within 52.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.